Acquired reactive perforating collagenosis and pseudoporphyric bullous dermatosis in a hemodialysis patient

被引:4
|
作者
Sabanis, Nikos [1 ]
Paschou, Eleni [2 ]
Gavriilaki, Eleni [3 ]
Kalaitzoglou, Asterios [3 ]
Papanikolaou, Dimitrios [4 ]
Vasileiou, Sotiris [1 ]
Amplianitis, Ioannis [5 ]
机构
[1] Gen Hosp Pella, Dept Nephrol, Edessa, Greece
[2] Gen Hosp Pella, Dept Gen Practice & Family Med, Edessa, Greece
[3] Aristotle Univ Thessaloniki, Med Sch, Thessaloniki, Greece
[4] Gen Hosp Pella, Dept Gen Surg, Edessa, Greece
[5] Gen Hosp Hippokrate, Dept Pathol, Thessaloniki, Greece
关键词
Hemodialysis; skin disorders; acquired reactive perforating collagenosis; pseudoporphyria cutanea tarda; ORAL N-ACETYLCYSTEINE; DIALYSIS; ALLOPURINOL; DISEASE;
D O I
10.1111/hdi.12402
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hemodialysis patients present with a broad spectrum of specific and nonspecific skin disorders, which rarely coexist. We report an exceptional case of a hemodialysis patient that developed acquired reactive perforating collagenosis and pseudoporphyric bullous dermatosis on the basis of common skin disorders which include hyperpigmentation, pruritus, xerosis cutis, and Linsday's nails. Interestingly, our patient presented with two unusual but distinctive cutaneous dermopathies on the background of other commonly seen skin alterations. The patient was successfully treated with allopurinol and N-acetylcysteine. Avoidance of potentially triggering factors such as alcohol, sunlight exposure and certain medication was recommended. Thus, increasing clinical awareness, assiduous investigation and early treatment of skin disorders are required to improve the prognosis and quality of life in this patient population.
引用
收藏
页码:E14 / E18
页数:5
相关论文
共 50 条
  • [1] Localized Bullous Pemphigoid in a Patient with Acquired Reactive Perforating Collagenosis
    Oka, Masahiro
    CASE REPORTS IN DERMATOLOGY, 2023, 15 (01): : 1 - 4
  • [2] Two Cases of Acquired Reactive Perforating Collagenosis in Hemodialysis Patients
    Xu, Min
    Cao, Fale
    Shi, Shumei
    SEMINARS IN DIALYSIS, 2025,
  • [3] Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: Successful treatment with allopurinol
    Iyoda, M
    Hayashi, F
    Kuroki, A
    Shibata, T
    Kitazawa, K
    Sugisaki, T
    Sakai, O
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03)
  • [4] Acquired reactive perforating collagenosis: Current status
    Karpouzis, Anthony
    Giatromanolaki, Alexandra
    Sivridis, Efthimios
    Kouskoukis, Constantin
    JOURNAL OF DERMATOLOGY, 2010, 37 (07) : 585 - 592
  • [5] Acquired Reactive Perforating Collagenosis
    Singhania, Namrata
    Singhania, Girish
    Al-Rabadi, Laith
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (11) : 1086 - 1087
  • [6] Acquired Reactive Perforating Collagenosis
    Ataseven, Arzu
    Kayacetin, Serra
    EURASIAN JOURNAL OF MEDICINE, 2012, 44 (01) : 51 - 53
  • [7] Acquired Reactive Perforating Collagenosis
    Namrata Singhania
    Girish Singhania
    Laith Al-Rabadi
    Clinical and Experimental Nephrology, 2020, 24 : 1086 - 1087
  • [8] Acquired reactive perforating collagenosis in a patient with lung fibrosis
    Tsuboi, H
    Mukuno, A
    Sato, N
    Katsuoka, K
    Yanase, N
    JOURNAL OF DERMATOLOGY, 2004, 31 (11) : 916 - 919
  • [9] Characteristics of acquired reactive perforating collagenosis
    Tsuboi, Hiromi
    Katsuoka, Kensei
    JOURNAL OF DERMATOLOGY, 2007, 34 (09) : 640 - 644
  • [10] Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis
    Maki, Nobuki
    Nishie, Wataru
    Takazawa, Maya
    Kakurai, Maki
    Yamada, Tomoko
    Umemoto, Naoka
    Kawase, Masaaki
    Izumi, Kentaro
    Shimizu, Hiroshi
    Demitsu, Toshio
    JOURNAL OF DERMATOLOGY, 2018, 45 (05) : 600 - 602